About: Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.30 (+1.74%)
CNTX NASDAQ Context Therapeutics Inc
Context Therapeutics Inc share price
CNTX price activity
Last Price
$0.300
Change (24hr)
0.01 USD (1.74%)
Volume
575.73K
Volume (4w avg)
-
Open
$0.30
Day Range
$0.30 - $0.31
Previous Close
$0.30
Last Trade
09 Oct, 8:26 pm GMT+0
Delayed
09 Oct, 8:26 pm GMT+0
CNTX price performance
Delayed
09 Oct, 8:26 pm GMT+0
CNTX Market Signals